Delirium clinical trials at UC Cancer
1 research study open to eligible people
open to eligible people ages up to 21 years
Children undergoing stem cell transplants are at risk for delirium, a temporary change in thinking and behavior. This study will define delirium rates, risk factors, and outcomes. Our eventual goal is to reduce delirium in this population.
Our lead scientists for Delirium research studies include Sandhya Kharbanda, MD.